Literature DB >> 23493376

Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products.

Joan M Vaughan1, Cynthia J Donaldson, Wolfgang H Fischer, Marilyn H Perrin, Jean E Rivier, Paul E Sawchenko, Wylie W Vale.   

Abstract

Mouse (m) and human (h) urocortin 2 (Ucn 2) were identified by molecular cloning strategies and the primary sequence of their mature forms postulated by analogy to closely related members of the corticotropin-releasing factor (CRF) neuropeptide family. Because of the paucity of Ucn 2 proteins in native tissues, skin, muscle, and pancreatic cell lines were transduced with lentiviral constructs and secretion media were used to isolate and characterize Ucn 2 products and study processing. Primary structures were assigned using a combination of Edman degradation sequencing and mass spectrometry. For mUcn 2, transduced cells secreted a 39 amino acid peptide and the glycosylated prohormone lacking signal peptide; both forms were C-terminally amidated and highly potent to activate the type 2 CRF receptor. Chromatographic profiles of murine tissue extracts were consistent with cleavage of mUcn 2 prohormone to a peptidic form. By contrast to mUcn 2, mammalian cell lines transduced with hUcn 2 constructs secreted significant amounts of an 88 amino acid glycosylated hUcn 2 prohormone but were unable to further process this molecule. Similarly, WM-266-4 melanoma cells that express endogenous hUcn 2 secreted only the glycosylated prohormone lacking the signal peptide and unmodified at the C terminus. Although not amidated, hUcn 2 prohormone purified from overexpressing lines activated CRF receptor 2. Hypoxia and glycosylation, paradigms that might influence secretion or processing of gene products, did not significantly impact hUcn 2 prohormone cleavage. Our findings identify probable Ucn 2 processing products and should expedite the characterization of these proteins in mammalian tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23493376      PMCID: PMC3602626          DOI: 10.1210/en.2012-2011

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

1.  Evidence that glycosylation of pro-opiocortin and ACTH influences their proteolysis by trypsin and blood proteases.

Authors:  Y P Loh; H Gainer
Journal:  Mol Cell Endocrinol       Date:  1980-10       Impact factor: 4.102

2.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.

Authors:  E M Fekete; Y Zhao; A Szücs; V Sabino; P Cottone; J Rivier; W W Vale; G F Koob; E P Zorrilla
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 4.  The CRF peptide family and their receptors: yet more partners discovered.

Authors:  Frank M Dautzenberg; Richard L Hauger
Journal:  Trends Pharmacol Sci       Date:  2002-02       Impact factor: 14.819

5.  Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.

Authors:  A Chanalaris; K M Lawrence; A Stephanou; R D Knight; S Y Hsu; A J W Hsueh; D S Latchman
Journal:  J Mol Cell Cardiol       Date:  2003-10       Impact factor: 5.000

6.  Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.

Authors:  Emmanouil Karteris; Edward W Hillhouse; Dimitris Grammatopoulos
Journal:  Endocrinology       Date:  2003-10-30       Impact factor: 4.736

7.  Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.

Authors:  Eric P Zorrilla; Lindsay E Reinhardt; Glenn R Valdez; Koki Inoue; Jean E Rivier; Wylie W Vale; George F Koob
Journal:  J Pharmacol Exp Ther       Date:  2004-04-28       Impact factor: 4.030

8.  Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.

Authors:  Alon Chen; Amy Blount; Joan Vaughan; Bhawanjit Brar; Wylie Vale
Journal:  Endocrinology       Date:  2004-01-21       Impact factor: 4.736

9.  Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta.

Authors:  Kazunori Kageyama; Ken-Ichi Furukawa; Izumi Miki; Ken Terui; Shigeru Motomura; Toshihiro Suda
Journal:  J Cardiovasc Pharmacol       Date:  2003-10       Impact factor: 3.105

10.  Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.

Authors:  Bhawanjit K Brar; Alon Chen; Marilyn H Perrin; Wylie Vale
Journal:  Endocrinology       Date:  2003-12-11       Impact factor: 4.736

View more
  5 in total

1.  Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.

Authors:  Pu-Qing Yuan; S Vincent Wu; Charalabos Pothoulakis; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

Review 2.  New techniques, applications and perspectives in neuropeptide research.

Authors:  Kellen DeLaney; Amanda R Buchberger; Louise Atkinson; Stefan Gründer; Angela Mousley; Lingjun Li
Journal:  J Exp Biol       Date:  2018-02-08       Impact factor: 3.312

Review 3.  CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Neurosci       Date:  2014-03-18       Impact factor: 4.677

Review 4.  Gut-Brain Neuroendocrine Signaling Under Conditions of Stress-Focus on Food Intake-Regulatory Mediators.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

5.  Urocortin 2 promotes hypertrophy and enhances skeletal muscle function through cAMP and insulin/IGF-1 signaling pathways.

Authors:  Natalia Lautherbach; Dawit A P Gonçalves; Wilian A Silveira; Sílvia Paula-Gomes; Rafael Rossi Valentim; Neusa M Zanon; Marcelo G Pereira; Elen H Miyabara; Luiz C C Navegantes; Isis C Kettelhut
Journal:  Mol Metab       Date:  2022-04-04       Impact factor: 8.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.